Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway

Figure 6

Effects of EGCG on HFD-induced NAFLD in mice. (a) Representative photographs of mice in each group. (b, c) The body weights of mice were measured. (d, e) Food intake and water intake were determined. (f–h) The liver weight, white fat weight, and brown fat weight were calculated. (i–l) The levels of TC, TG, ALT, and AST in the plasma of mice were detected. (m–o) The expression levels of TC, TG, and NEFA in the liver of mice were detected. Data are presented as (). , compared with the control group; ^## compared with the OA group.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)